‘I need policymakers to listen’: a public and professionals needs assessment concerning anticipatory injectable medication systems, using a novel qualitative survey

Abstract Background Anticipatory injectable medications for symptom control are a key end-of-life care intervention internationally. Research has focused largely on the perspectives of doctors and nurses, with limited understanding of the wider stakeholder network involved in community-based systems for using anticipatory injectable medications. This study aimed to identify the needs and priorities of a wide range of stakeholders involved in their use in community-based systems. Methods We adopted a qualitative exploratory design, using an UK-wide online survey between September and October 2024. Participants provided anonymised demographic information and completed up to four prompts capturing their: stakeholder role (as a…): needs (I need...), and priorities (so that…). Data were analysed using a combined inductive–deductive framework to produce shortlists of stakeholder priorities and needs. Results In total, 439 participants contributed 729 responses across multiple stakeholder groups. Findings revealed substantial diversity in stakeholder needs and priorities, both within and between groups. Some public and professional stakeholders expressed competing priorities and needs. Most stakeholder groups prioritised timely care, minimising of suffering, and wanted nationally consistent guidance for using injectable medications. Responses also reflected concerns about healthcare resource constraints and the potential implications of assisted dying legislation on systems for using medications. Conclusions Our findings highlight the wide diversity in priorities and needs between stakeholders involved in the use of anticipatory injectable medications. Understanding these differing priorities may support the design of more inclusive and responsive community-based systems for their use.

Authors

Institutions

Publication Details

Journal
BMC Palliative Care
Published
2026-11-17
DOI
https://doi.org/10.1186/s12904-026-02427-z
Primary Topic
Palliative Care and End-of-Life Issues
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

‘I need policymakers to listen’: a public and professionals needs assessment concerning anticipatory injectable medication systems, using a novel qualitative survey

Ben Bowers, Binu Perera
2 links
BMC Palliative Care
Palliative Care and End-of-Life Issues
article

‘I need policymakers to listen’: a public and professionals needs assessment concerning anticipatory injectable medication systems, using a novel qualitative survey

Ben Bowers, Binu Perera
article en

Abstract

Abstract Background Anticipatory injectable medications for symptom control are a key end-of-life care intervention internationally. Research has focused largely on the perspectives of doctors and nurses, with limited understanding of the wider stakeholder network involved in community-based systems for using anticipatory injectable medications. This study aimed to identify the needs and priorities of a wide range of stakeholders involved in their use in community-based systems. Methods We adopted a qualitative exploratory design, using an UK-wide online survey between September and October 2024. Participants provided anonymised demographic information and completed up to four prompts capturing their: stakeholder role (as a…): needs (I need...), and priorities (so that…). Data were analysed using a combined inductive–deductive framework to produce shortlists of stakeholder priorities and needs. Results In total, 439 participants contributed 729 responses across multiple stakeholder groups. Findings revealed substantial diversity in stakeholder needs and priorities, both within and between groups. Some public and professional stakeholders expressed competing priorities and needs. Most stakeholder groups prioritised timely care, minimising of suffering, and wanted nationally consistent guidance for using injectable medications. Responses also reflected concerns about healthcare resource constraints and the potential implications of assisted dying legislation on systems for using medications. Conclusions Our findings highlight the wide diversity in priorities and needs between stakeholders involved in the use of anticipatory injectable medications. Understanding these differing priorities may support the design of more inclusive and responsive community-based systems for their use.

BMC Palliative Care
University of Cambridge (GB), MRC Biostatistics Unit (GB)
Wellcome Trust, National Institute for Health and Care Research, Department of Health and Social Care, Marie Curie
Good health and well-being
Palliative Care and End-of-Life Issues
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon